Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

NCT06046612 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction
Microvascular Dysfunction

Interventions

DRUG: Participants receive 10mg Empaglifozin once daily on prescription from their treating physician. This is not an intervention in this trial, but part of their normal HFpEF treatment

Sponsor

Maastricht University Medical Center